For: | Li R, Liao XH, Ye JZ, Li MR, Wu YQ, Hu X, Zhong BH. Association of keratin 8/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: A case-control study. World J Gastroenterol 2017; 23(22): 4047-4053 [PMID: 28652657 DOI: 10.3748/wjg.v23.i22.4047] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i22/4047.htm |
Number | Citing Articles |
1 |
Congxiang Shao, Junzhao Ye, Fuxi Li, Shiting Feng, Wei Wang, Bihui Zhong. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. Digestive and Liver Disease 2019; 51(10): 1392 doi: 10.1016/j.dld.2019.02.019
|
2 |
Younglan Lim, Nam-On Ku. Revealing the Roles of Keratin 8/18-Associated Signaling Proteins Involved in the Development of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(12): 6401 doi: 10.3390/ijms22126401
|
3 |
Cong xiang Shao, Junzhao Ye, Zhi Dong, Fuxi Li, Yansong Lin, Bing Liao, Shiting Feng, Bihui Zhong. Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease. Therapeutic Advances in Chronic Disease 2021; 12 doi: 10.1177/20406223211033119
|
4 |
Minh Ho, Brian Thompson, Jeffrey Nicholas Fisk, Daniel W. Nebert, Elspeth A. Bruford, Vasilis Vasiliou, Christopher G. Bunick. Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders. Human Genomics 2022; 16(1) doi: 10.1186/s40246-021-00374-9
|
5 |
Naga Swetha Samji, Peter D. Snell, Ashwani K. Singal, Sanjaya K. Satapathy. Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease. Clinical Liver Disease 2020; 16(2): 66 doi: 10.1002/cld.948
|
6 |
João Pessoa, José Teixeira. Cytoskeleton alterations in non-alcoholic fatty liver disease. Metabolism 2022; 128: 155115 doi: 10.1016/j.metabol.2021.155115
|
7 |
Zhuoran Han, Lunhua Ge, Siyi Wen, Jingfeng Sun. Dysfunction of the intestinal physical barrier in the intestinal inflammation of tongue sole, Cynoglossus semilaevis, induced by Shewanella algae infection. Fish & Shellfish Immunology 2023; 139: 108900 doi: 10.1016/j.fsi.2023.108900
|
8 |
Qianqian Ma, Xianhua Liao, Congxiang Shao, Yansong Lin, Tingfeng Wu, Yanhong Sun, Shi-Ting Feng, Junzhao Ye, Bihui Zhong. Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01790-w
|
9 |
L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.597583
|
10 |
Junzhao Ye, Yanqin Wu, Minrui Li, Xiaorong Gong, Bihui Zhong. Keratin 8 Mutations Were Associated With Susceptibility to Chronic Hepatitis B and Related Progression. The Journal of Infectious Diseases 2019; doi: 10.1093/infdis/jiz467
|
11 |
Xueqin Li, Qianqian Song, Xueru Guo, Limin Wang, Qicheng Zhang, Limin Cao, Yinghui Ren, Xiang Wu, Zhaowei Meng, Ke Xu. <p>The Metastasis Potential Promoting Capacity of Cancer-Associated Fibroblasts Was Attenuated by Cisplatin via Modulating KRT8</p>. OncoTargets and Therapy 2020; : 2711 doi: 10.2147/OTT.S246235
|
12 |
Fei Teng, Sree Sankar Darveekaran Nair, Pengfei Zhu, Shanshan Li, Shi Huang, Xiaolan Li, Jian Xu, Fang Yang. Impact of DNA extraction method and targeted 16S-rRNA hypervariable region on oral microbiota profiling. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34294-x
|
13 |
Congxiang Shao, Junzhao Ye, Fuxi Li, Yansong Lin, Tingfeng Wu, Wei Wang, Shiting Feng, Bihui Zhong. Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients. Digestive Diseases and Sciences 2020; 65(6): 1850 doi: 10.1007/s10620-019-05926-7
|
14 |
Wei-Kei Wong, Wah-Kheong Chan. Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics 2021; 43(3): 473 doi: 10.1016/j.clinthera.2021.01.007
|